Debts
€697,551 ▲ 52.5%
Debts rose by €240,045 in 2025.
DALEMANS
Lifetime
20 annual accounts with figures on one time axis, 46 filings since 1980peak €125,083 (2011)
€63,647▲ 0.5%
lowest -€22,317 (2025)
-€22,317▼ €45,054
peak €522,665 (2023)
€500,348▼ 4.3%
€697,551▲ 52.5%
peak 1 FTE (2006)
1 FTE
Board2 names since 1979
1 director
Owners
100%
Documentsfilings and deeds
31-08-202631 days late
2025abbreviated format
Loss of €22,317Debts from €457,506 to €697,551Investments €599,503Cash from €348,228 to €60,253
Key points
from the 2025 annual accountsInvestments
€599,503 16.6 × depreciation
Green is investment, beige is depreciation. Machinery stands 2068.4% higher than in 2024.
Staff
1 employees on 31-12-2025
In 2025, 1 person joined and nobody left.
Liquidity
1.25 was 3.04 in 2024
Short-term debts rose from €228,745 to €279,327.
Filings
46 annual accounts since 1980
Ten of the last ten came late. The 2022 accounts came latest: 144 days after the end of the period.
Position in the sector
-€22,317
Lower net result than 85% of companies in retail trade. Sector median €38,016 · 13,231 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 12,322 companies had the same profile as DALEMANS has now. Each dot stands for 31 companies, two years later.
90.3%
were still trading
8.5%
stopped another way
0.7%
went bankrupt
Another 0.4% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 12,322 companies, not a prediction for DALEMANS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director,
- 100%equity €114,209 (2025) · 2025 annual accounts of
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0419971002
Registered office moved within Buggenhout
New registered office: Paul Van Malderenplein 5, 9255 Buggenhout · Previous registered office: Kerkstraat 75, 9255 Buggenhout · General meeting of 15-04-2026 · Gazette deed
Environmental permit granted
Nieuwe publiciteitsinrichting (met inbegrip van vernieuwen van een bestaande vergunning), Verbouwen en/of uitbreiden met functiewijziging, maar zonder wijziging van het aantal woongelegenheden · Buggenhout
Company renamed from MARC ADRIAENSSENS to Dalemans
Resignation: (statutory manager) · Appointment: (director) · Permanent representative: · General meeting of 31-01-2023 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DALEMANS Buggenhout | €1.2m | €63,647 | 41.8% | 1 |
| APOTHEEK BAETENS Evergem | €1.2m | €55,703 | 42.1% | 1 |
| APOTHEEK JANS Riemst | €1.2m | €83,468 | 12.6% | 0.9 |
| PHARMACIE LECLERCQ Soignies | €0.8m | €73,752 | 70.1% | 0.8 |
| PACHECO Braine-l'Alleud | €1.2m | €41,850 | 37.6% | 1.6 |
| APOTHEEK ZUIDERKRUIS Antwerp | €1.4m | €110,172 | 11.2% | 1.1 |
| APOTHEEK HUMBLET Zoutleeuw | €0.9m | €90,354 | 2.8% | 1.6 |
These companies have the same main activity as DALEMANS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €833,000 and €1.4m, founded between 1969 and 1990.
Official details
Source: KBO- Status
- Active since 21-12-1979Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2021
- Establishment unit
- 2.016.972.5679255 Buggenhout, since 01-01-1980
- Financial year end
- 31 December
- Peppol
- Reachable since 21-10-2026
Annual accounts 2025
- ≈ €310,000estimated
- €1.2m▲ 22.2%
- Employeeson 31-12-2025
- 1
- Filing
- Filed on 31-08-2026
Insights on DALEMANS
DALEMANS files the abbreviated format. That format states no turnover. The gross margin rose from €52,717 in 2006 to €63,647 in 2025.
The balance sheet grew most in 2023 through fixed assets.
holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DALEMANS
- What is the company number of DALEMANS?
- The company number of DALEMANS is 0419.971.002. The VAT number is the same number with BE in front: BE 0419.971.002.
- Where is DALEMANS based?
- The registered office is at Paul Van Malderenplein 5, 9255 Buggenhout.Company details
- What does DALEMANS do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of DALEMANS?
- DALEMANS is a private limited company (BV).
- When was DALEMANS founded?
- DALEMANS was founded on 21-12-1979.
- Is DALEMANS still active?
- Yes, DALEMANS is an active enterprise in the KBO register.
- How many employees does DALEMANS have?
- DALEMANS had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does DALEMANS fall under?
- In its 2021 annual accounts, DALEMANS states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of DALEMANS?
- The turnover in financial year 2025 is ≈ €310,000. This figure is estimated from the gross margin of €63,647 and 74 comparable companies (NACE 477). It probably lies between €160,000 and €450,000.
- Is DALEMANS profitable?
- In financial year 2025, DALEMANS made a loss of €22,317.
- Where can I find the annual accounts of DALEMANS?
- DALEMANS filed 46 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DALEMANS due?
- DALEMANS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.